PAIN.V Vector Science and Therapeutics Corp.

Healthcare Medical Devices TSX Venture Exchange
2.15 CAD
Close of Nov 7, 2026
0.3500 2.65
Market cap
CAD 336M
P/E
-
P/B
117.53x
ROE
-255.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to May 2026.

Is PAIN.V undervalued?

Graham number

The Graham number of Vector Science and Therapeutics Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Vector Science and Therapeutics Corp. fundamental analysis

No fundamental analysis for Vector Science and Therapeutics Corp. yet.

Vector Science and Therapeutics Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Vector Science and Therapeutics Corp.

Vector Science and Therapeutics Corp. develops precision biomechanical devices and active transdermal delivery systems for musculoskeletal regeneration. The company offers cGMP-manufactured Rx peptides for physicians and patients across sports, regenerative, and longevity medicine channels. It also provides VectorMist, a commercial precision therapeutic platform, as well as Valor, a delivery system and transdermal platform. The company is based in Mequon, Wisconsin.

Full company profile